62011-0199 : Health Mart Nicotine Polacrilex 2 mg/1 Oral Lozenge


NDC: 62011-0199
Labeler: Mckesson
Product Type: Human OTC Drug
Drug Name:  Health Mart Nicotine Polacrilex
Dosage Form: Oral Lozenge
Application #: ANDA203690
Rev. Date: 


NDC Package Codes:

  • 62011-0199-1: 3 CONTAINER IN 1 CARTON (62011‑0199‑1) > 27 LOZENGE IN 1 CONTAINER

Active Ingredients:

  • Nicotine

Dosage Strength:

  • 2 mg

Pharmaceutical Classes:

  • Cholinergic Nicotinic Agonist [EPC]
  • Nicotine [CS]

Related Products:

Based on records with the same trade name.
  • 62011-0425 Health Mart Nicotine Polacrilex 2 mg Oral Gum, Chewing by Strategic Sourcing Services LLC
  • 62011-0426 Health Mart Nicotine Polacrilex 4 mg Oral Gum, Chewing by Strategic Sourcing Services LLC
  • 62011-0427 Health Mart Nicotine Polacrilex 2 mg Oral Lozenge by Strategic Sourcing Services LLC
  • 62011-0428 Health Mart Nicotine Polacrilex 4 mg Oral Lozenge by Strategic Sourcing Services LLC
  • 62011-0429 Health Mart Nicotine Polacrilex 2 mg Oral Lozenge by Strategic Sourcing Services LLC
  • 62011-0430 Health Mart Nicotine Polacrilex 4 mg Oral Lozenge by Strategic Sourcing Services LLC

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 62011-0199 QR Code

< Prev: 62011-0198Next: 62011-0200 >

Related Discussions:

Nicotine patches and lozenges
I'm finally over the smoking cigarettes I hope LOL. I used the smoking aid, nicotine transdermal system 14mg, then t... 1 reply
A Rx nicotine patch that starts with a P
In 1992 in Talahassee Fl, a Dr prescribed this patch that was new to the market at that tiune. I had smoked for 35 years...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.